Disc Medicine (IRON) News Today $47.13 +2.31 (+5.15%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Iron supplements may boost brain development in children with HIVNovember 2 at 7:26 AM | msn.comDisc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)November 1 at 4:01 PM | globenewswire.comStudy demonstrates efficacy of iron supplements for children living with HIVNovember 1 at 3:31 AM | msn.comShort Interest in Disc Medicine, Inc. (NASDAQ:IRON) Drops By 6.9%November 1 at 3:21 AM | americanbankingnews.comDisc Medicine, Inc. (NASDAQ:IRON) Short Interest Down 6.9% in OctoberDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 1,480,000 shares, a decrease of 6.9% from the September 30th total of 1,590,000 shares. Based on an average daily trading volume, of 215,400 shares, the days-to-cover ratio is currently 6.9 days. Approximately 9.5% of the shares of the stock are short sold.October 31 at 4:06 AM | marketbeat.comDisc Medicine's (IRON) Buy Rating Reaffirmed at HC WainwrightOctober 29, 2024 | americanbankingnews.comDisc Medicine’s Promising Anemia Treatment Drives Buy RatingOctober 28, 2024 | markets.businessinsider.comDisc Medicine (IRON) Receives a Buy from ScotiabankOctober 28, 2024 | markets.businessinsider.comPromising Prospects for Disc Medicine: Innovative Anemia Treatment and Regulatory Milestones Drive Buy RatingOctober 28, 2024 | markets.businessinsider.comDisc Medicine's (IRON) Buy Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $70.00 target price on shares of Disc Medicine in a report on Monday.October 28, 2024 | marketbeat.comDisc Medicine Reports Positive Phase 1b Results For DISC-0974 In Chronic Kidney Disease And AnemiaOctober 27, 2024 | markets.businessinsider.comDisc Medicine’s DISC-0974 Shows Promising Potential for Anemia Treatment, Earning Buy RatingOctober 25, 2024 | markets.businessinsider.comDisc Medicine Reports Promising Phase 1b Trial ResultsOctober 25, 2024 | markets.businessinsider.comDisc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney WeekOctober 25, 2024 | globenewswire.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Sangamo Biosciences (SGMO) and Disc Medicine (IRON)October 24, 2024 | markets.businessinsider.comJefferies Initiates Coverage of Disc Medicine (IRON) with Buy RecommendationOctober 24, 2024 | msn.comBrokerages Set Disc Medicine, Inc. (NASDAQ:IRON) Price Target at $63.89October 24, 2024 | americanbankingnews.comDisc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical OfficerOctober 23, 2024 | markets.businessinsider.comDisc Medicine initiated with a Buy at JefferiesOctober 23, 2024 | markets.businessinsider.comDisc Medicine draws but at Jefferies on lead assetOctober 23, 2024 | msn.comDisc Medicine (NASDAQ:IRON) Shares Gap Up - Here's WhyDisc Medicine (NASDAQ:IRON) Shares Gap Up - What's Next?October 23, 2024 | marketbeat.comDisc Medicine (NASDAQ:IRON) Now Covered by Analysts at Jefferies Financial GroupJefferies Financial Group began coverage on Disc Medicine in a research report on Wednesday. They issued a "buy" rating and a $89.00 price target on the stock.October 23, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Given Average Recommendation of "Moderate Buy" by AnalystsDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has received a consensus rating of "Moderate Buy" from the nine brokerages that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The averOctober 21, 2024 | marketbeat.comScotiabank Initiates Coverage of Disc Medicine (IRON) with Sector Outperform RecommendationOctober 18, 2024 | msn.comDisc Medicine, Inc. (NASDAQ:IRON) Sees Significant Growth in Short InterestDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) saw a large growth in short interest in September. As of September 30th, there was short interest totalling 1,590,000 shares, a growth of 13.6% from the September 15th total of 1,400,000 shares. Approximately 10.2% of the company's stock are short sold. Based on an average trading volume of 207,800 shares, the days-to-cover ratio is currently 7.7 days.October 16, 2024 | marketbeat.comDisc Medicine (NASDAQ:IRON) Earns Sector Outperform Rating from Analysts at ScotiabankScotiabank began coverage on shares of Disc Medicine in a research report on Wednesday. They set a "sector outperform" rating for the company.October 16, 2024 | marketbeat.comCantor Fitzgerald Reiterates "Overweight" Rating for Disc Medicine (NASDAQ:IRON)Cantor Fitzgerald restated an "overweight" rating and issued a $85.00 price target on shares of Disc Medicine in a research note on Tuesday.October 15, 2024 | marketbeat.comDoctors Say This Is the Best Time to Take Iron SupplementsOctober 15, 2024 | msn.comDisc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney WeekOctober 11, 2024 | globenewswire.comIf You're Tired All The Time, Iron Deficiency May Be To Blame. Doctors Share How To Spot It.October 11, 2024 | msn.comMarshall Wace LLP Invests $554,000 in Disc Medicine, Inc. (NASDAQ:IRON)Marshall Wace LLP acquired a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 12,300 shares of the company's stock, valued at approximatelOctober 10, 2024 | marketbeat.comDisc Medicine (NASDAQ:IRON) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comDisc Medicine (NASDAQ:IRON) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comDisc Medicine: Achieving Functional Endpoint More ImportantOctober 6, 2024 | seekingalpha.comTeachers Retirement System of The State of Kentucky Makes New $636,000 Investment in Disc Medicine, Inc. (NASDAQ:IRON)Teachers Retirement System of The State of Kentucky purchased a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 14,102 shares of tOctober 6, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director William Richard White Sells 201 SharesOctober 4, 2024 | insidertrades.comTikTok users claim a cast iron ‘fish’ can help with a mineral deficiency – but it’s not quite that simpleOctober 1, 2024 | ca.news.yahoo.comNantahala Capital Management LLC Takes Position in Disc Medicine, Inc. (NASDAQ:IRON)Nantahala Capital Management LLC purchased a new stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 150,000 shares of the company's stock, valued at approximately $6,760,000October 1, 2024 | marketbeat.comPerceptive Advisors LLC Lowers Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Perceptive Advisors LLC reduced its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 13.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 553,437 shares of the company's stock after selSeptember 30, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Has $79.09 Million Stake in Disc Medicine, Inc. (NASDAQ:IRON)Frazier Life Sciences Management L.P. lifted its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 123.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,754,834 shares of the company's stock after bSeptember 29, 2024 | marketbeat.comBlue Owl Capital Holdings LP Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Blue Owl Capital Holdings LP increased its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 38.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 215,260 shares of the company's stock after aSeptember 28, 2024 | marketbeat.comNearly 1 in 3 US adults may have an iron deficiency, study suggestsSeptember 28, 2024 | msn.comPoint72 Asset Management L.P. Acquires Shares of 761,429 Disc Medicine, Inc. (NASDAQ:IRON)Point72 Asset Management L.P. acquired a new stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 761,429 shares of the company's stSeptember 27, 2024 | marketbeat.com4 in 5 Pregnant Women Become Iron Deficient: 'Staggering' Says DoctorSeptember 26, 2024 | msn.comDeerfield Management Company L.P. Series C Purchases 357,730 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Deerfield Management Company L.P. Series C increased its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 53.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,023,265 shares of the company's stock after acquiring an additionaSeptember 26, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and seven have issued a buy raSeptember 26, 2024 | marketbeat.comDoctors Are Sharing The 7 Sneakiest Causes Of Back PainSeptember 25, 2024 | uk.style.yahoo.comIron deficiency could be impacting almost a third of American adults, Boston hospital's study saysSeptember 25, 2024 | cbsnews.com77 Things You Should Never Throw Out (and How to Reuse Them)September 24, 2024 | msn.comHidden Iron Deficiency May Affect 1 in 6 Americans, Study FindsSeptember 24, 2024 | newsweek.com Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here IRON Media Mentions By Week IRON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRON News Sentiment▼0.700.43▲Average Medical News Sentiment IRON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRON Articles This Week▼134▲IRON Articles Average Week Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ardelyx News Landsea Homes News Puma Biotechnology News Quantum-Si News PolyPid News Biohaven News Crinetics Pharmaceuticals News Ultragenyx Pharmaceutical News Immunovant News Cybin News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRON) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
